Leadership Overview
Myriad Genetics has 10 executives leading key functions including strategy, operations, technology, finance, information systems, human resources, sales, women's health, and general leadership.
Driven by innovation, Myriad Genetics specializes in discovering and delivering tests across major diseases, impacting global health through advanced molecular diagnostics.
Driven by innovation, Myriad Genetics specializes in discovering and delivering tests across major diseases, impacting global health through advanced molecular diagnostics.
Leadership Roles at Myriad Genetics
James Daniel - Chief Executive Officer
James Daniel, the Chief Executive Officer at Myriad Genetics, directs the company's overarching strategy and operational execution. Daniel guides the organization's mission to discover and deliver transformative molecular diagnostic tests across critical disease areas. This leadership role involves setting the strategic vision for research and development, ensuring alignment with market needs, and driving growth initiatives. Daniel's focus remains on advancing the company's position in the molecular diagnostics sector, leveraging scientific innovation to address unmet medical needs. The Chief Executive Officer oversees all major business units, ensuring cohesive performance and strategic direction. James Daniel's leadership ensures Myriad Genetics remains at the forefront of diagnostic innovation, impacting patient care globally.
Sam Raha - President & Chief Executive Officer
Sam Raha, the President & Chief Executive Officer at Myriad Genetics, spearheads the company's strategic direction and global operations. Raha drives the expansion of Myriad Genetics' molecular diagnostic offerings, focusing on delivering tests that address significant health challenges. This executive position involves overseeing all facets of the business, from research and development to commercialization and market penetration. Raha's mandate includes fostering innovation, optimizing operational efficiency, and ensuring the company's financial health and long-term sustainability. The President & Chief Executive Officer works closely with the board and executive team to achieve strategic objectives. Sam Raha's leadership is pivotal in advancing the company's mission to improve patient outcomes through precise diagnostic insights.
Benjamin Wheeler - Chief Financial Officer
Benjamin Wheeler, the Chief Financial Officer at Myriad Genetics, oversees all financial operations and strategic financial planning for the company. Wheeler manages financial reporting, budgeting, forecasting, and capital allocation to support Myriad Genetics' growth and innovation in molecular diagnostics. This critical role involves ensuring financial stability, optimizing resource deployment, and driving shareholder value. The Chief Financial Officer works closely with executive leadership to develop financial strategies that align with the company's mission of delivering transformative tests across major diseases. Benjamin Wheeler's financial acumen is essential for navigating the complex healthcare market and supporting sustained investment in research and development. This leadership ensures robust financial health for Myriad Genetics.
Yigit Arslanoglu - Chief Operating Officer
Yigit Arslanoglu, the Chief Operating Officer at Myriad Genetics, manages the day-to-day operations and ensures efficient execution of the company's strategic initiatives. Arslanoglu oversees the operational infrastructure required for developing, manufacturing, and distributing molecular diagnostic tests across major disease categories. This role involves optimizing laboratory processes, supply chain management, and quality control to maintain high standards of service delivery. The Chief Operating Officer focuses on enhancing operational scalability and driving efficiencies to support the company's growth objectives. Arslanoglu's responsibilities include integrating new technologies and methodologies into existing workflows. Yigit Arslanoglu's operational oversight is critical for Myriad Genetics' ability to deliver accurate and timely diagnostic solutions to patients and healthcare providers.
Mike Whittington - President & Chairman & Chief Information Officer
Mike Whittington, the President & Chairman & Chief Information Officer at Myriad Genetics, provides strategic leadership across multiple critical functions. Whittington guides the company's overall direction as President and Chairman, while also directing the information technology strategy as Chief Information Officer. This dual focus ensures that technological infrastructure and information systems effectively support Myriad Genetics' mission of advancing molecular diagnostics. Whittington oversees the integration of IT solutions that enhance operational efficiency, data security, and research capabilities. The President & Chairman & Chief Information Officer plays a key part in corporate governance and strategic decision-making. Mike Whittington's comprehensive leadership ensures alignment between business objectives and technological advancements at Myriad Genetics.
Brett Davis - Sales Executive & President, S Club
Brett Davis, the Sales Executive & President, S Club at Myriad Genetics, drives commercial strategy and revenue generation. Davis leads sales initiatives focused on expanding the market reach of Myriad Genetics' molecular diagnostic tests across various disease areas. This role involves developing and executing sales plans, managing key client relationships, and motivating the sales team to achieve ambitious targets. The Sales Executive & President, S Club is instrumental in translating scientific advancements into commercial success. Brett Davis's leadership ensures that healthcare providers have access to Myriad Genetics' innovative diagnostic solutions, ultimately benefiting patient care. This focus on sales excellence supports the company's overall growth and mission.
Melissa Gonzales - President, Women's Health, Myriad Genetics
Melissa Gonzales, the President, Women's Health, Myriad Genetics, directs the strategic growth and operational success of the Women's Health division. Gonzales oversees the development, marketing, and commercialization of Myriad Genetics' specialized diagnostic tests focused on women's health conditions. This leadership position involves identifying market opportunities, fostering innovation within the division, and ensuring alignment with the company's broader mission. The President, Women's Health, Myriad Genetics works to enhance patient access to critical screening and diagnostic tools. Melissa Gonzales's dedicated focus on women's health ensures that Myriad Genetics continues to provide essential solutions that improve health outcomes for women globally. This leadership drives significant impact in a key therapeutic area.
Joel Schwartz - President
Joel Schwartz, the President at Myriad Genetics, provides executive leadership and strategic direction across key business functions. Schwartz oversees critical operational areas, ensuring alignment with Myriad Genetics' core mission of advancing molecular diagnostics for major diseases. This role involves driving performance, fostering cross-functional collaboration, and supporting the company's growth objectives. The President works to optimize business processes and enhance the delivery of innovative diagnostic solutions to patients and healthcare providers. Joel Schwartz's leadership contributes to the overall strategic execution and operational excellence of Myriad Genetics. This executive's focus is on ensuring the company's continued success and impact in the healthcare sector.
Kevin Haas - Chief Technology Officer
Kevin Haas, the Chief Technology Officer at Myriad Genetics, directs the company's technological vision and innovation strategy. Haas oversees the development and implementation of advanced technological platforms essential for molecular diagnostics, ensuring Myriad Genetics remains at the cutting edge of scientific discovery. This executive role involves managing IT infrastructure, data analytics, and cybersecurity to support the company's research, development, and commercial operations. The Chief Technology Officer is responsible for leveraging technology to enhance diagnostic capabilities and improve patient outcomes. Kevin Haas's expertise drives the integration of new digital tools and systems, optimizing workflows and data management. This leadership ensures the technological foundation supports Myriad Genetics' mission to deliver precise health insights.
Shereen Solaiman - Chief People Officer
Shereen Solaiman, the Chief People Officer at Myriad Genetics, leads human resources strategy and talent management initiatives. Solaiman is responsible for cultivating a positive and productive work environment that supports Myriad Genetics' mission of scientific innovation and patient care. This executive role involves overseeing talent acquisition, employee development, compensation and benefits, and fostering a strong organizational culture. The Chief People Officer ensures that the company attracts, retains, and develops the skilled workforce necessary to excel in the competitive molecular diagnostics field. Shereen Solaiman's strategic approach to human capital management is vital for driving employee engagement and supporting the company's ambitious goals. This leadership ensures Myriad Genetics has the talent to achieve its objectives.
Explore Leadership Teams in Business Services
IQVIA is a global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find solutions for their patients. IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIAs insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. IQVIA has dual headquarters in Danbury Connecticut and Durham, North Carolina.
Company Leadership JR
AF
AM
Founded in 1828, Bureau Veritas is an international certification agency. The company operates through the following businesses: Marine and Offshore, Industry, In-Service Inspection and Verification, Construction, Certification, Commodities, Consumer Products, and Government Services and International Trade. Bureau Veritas is based in France.
Company Leadership MB
AK
In 2006, MMS was created by Dr. Uma Sharma, with a vision to turn a one-person consultancy into a global, data-focused CRO that caters to the unique and often changing needs of sponsors. Years later, with an impeccable 97 percent customer satisfaction rating, MMS stays true to its dependable and customer-driven nature. A science-first approach and strong processes have smoothed the waters for MMS clients resulting in positive organic growth year over year, with more than 950 colleagues worldwide. MMS is a place where years of proven success have guided sponsors through their data services and regulatory submissions goals. When MMS takes on a project, colleagues become ingrained in that sponsor taking on a greater level of care and guiding them towards a positive outcome.
Company Leadership EP
MF
CS
MM
Founded in 1984, SCS Global Services provides third-party environmental and sustainability certification, auditing, testing, and standards development services to clients in the United States and internationally. SCS is located in Emeryville, California.
Company Leadership
KG
Frequently Asked Questions Regarding Myriad Genetics Top Executives and Leadership Team
Unlock more people and company data
